Review
Oral antiplatelet agents and chronic kidney disease
Affiliations
- PMID: 22143014
Item in Clipboard
Review
Oral antiplatelet agents and chronic kidney disease
Hellenic J Cardiol.
2011 Nov-Dec.
Free article
No abstract available
Similar articles
-
Effect of clopidogrel on arteriovenous fistulas for dialysis.JAMA. 2008 Oct 8;300(14):1647; author reply 1648-9. doi: 10.1001/jama.300.14.1647-a. JAMA. 2008. PMID: 18840831 No abstract available.
-
Effect of clopidogrel on arteriovenous fistulas for dialysis.JAMA. 2008 Oct 8;300(14):1648; author reply 1648-9. doi: 10.1001/jama.300.14.1648-a. JAMA. 2008. PMID: 18840832 No abstract available.
-
Antiplatelet therapy for patients with stents.Med Lett Drugs Ther. 2008 Aug 11;50(1292):61-3. Med Lett Drugs Ther. 2008. PMID: 18688203 No abstract available.
-
Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies.Clin Ther. 2010 Dec;32(14):2265-81. doi: 10.1016/j.clinthera.2011.01.003. Clin Ther. 2010. PMID: 21353100 Review.
-
Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.JAMA. 2004 Oct 20;292(15):1867-74. doi: 10.1001/jama.292.15.1867. JAMA. 2004. PMID: 15494585 Review.
Cited by
-
Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease.Sci Rep. 2022 Oct 22;12(1):17788. doi: 10.1038/s41598-022-22474-9. Sci Rep. 2022. PMID: 36273098 Free PMC article.
-
Use of Antiplatelet Agents and Survival of Tuberculosis Patients: A Population-Based Cohort Study.J Clin Med. 2019 Jun 27;8(7):923. doi: 10.3390/jcm8070923. J Clin Med. 2019. PMID: 31252593 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
